TipRanks
Go Ultimate55% OFF

Gregory Norden Insider Profile

4 Followers

Gregory Norden, Director at Praxis Precision Medicines, holds 1.56K shares in Praxis Precision Medicines (Ticker: PRAX), holds 196.35K shares in Royalty Pharma (Ticker: RPRX), holds 18.17K shares in Zoetis (Ticker: ZTS).

Gregory Norden's Trading History

PRAX
Praxis Precision Medicines
Jun 12, 2026DirectorUninformative Buy―$445.76K
RPRX
Royalty Pharma
Jun 08, 2026DirectorUninformative Buy―$13.19M
ZTS
Zoetis
Mar 10, 2026DirectorUninformative Sell―$1.45M
NSTGQ
NanoString Technologies
May 08, 2024―Uninformative Buy7.82K$6.29K
ETTX
Entasis Therapeutics Holdings
――――

You May Also Like

Gregory Norden insider profile FAQ

What is the percentage of profitable transactions made by Gregory Norden?
The percentage of profitable transactions made by Gregory Norden is 33%.
What is the average return per transaction made by Gregory Norden?
The average return per transaction made by Gregory Norden is -33.80%.
What stocks does Gregory Norden hold?
Gregory Norden holds: PRAX, ZTS, ETTX, RPRX, NSTGQ stocks.
What was Gregory Norden's most profitable transaction?
Gregory Norden’s most profitable transaction was an Informative Sell of ZTS stock on November 9, 2021. The return on the trade was 39.00%.
What is Gregory Norden's role in Praxis Precision Medicines?
Gregory Norden's role in Praxis Precision Medicines is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.